• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chemotherapy induced changes to fibrin clots properties in lung cancer: is it favorable?

作者信息

Sato Mitsuo

机构信息

Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

J Thorac Dis. 2019 May;11(Suppl 9):S1126-S1128. doi: 10.21037/jtd.2019.04.103.

DOI:10.21037/jtd.2019.04.103
PMID:31245061
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6560535/
Abstract
摘要

相似文献

1
Chemotherapy induced changes to fibrin clots properties in lung cancer: is it favorable?化疗引起的肺癌患者纤维蛋白凝块特性变化：这是有益的吗？
J Thorac Dis. 2019 May;11(Suppl 9):S1126-S1128. doi: 10.21037/jtd.2019.04.103.
2
[Loco-regional cancer chemotherapy with a new drug delivery system, "anticancer drug-fibrin clot"].
Gan To Kagaku Ryoho. 1989 Aug;16(8 Pt 2):2814-7.
3
The molecular origins of the mechanical properties of fibrin.纤维蛋白力学性能的分子起源。
Biophys Chem. 2010 Nov;152(1-3):15-20. doi: 10.1016/j.bpc.2010.08.009.
4
Role of clot-associated (-derived) thrombin in cell proliferation induced by fibrin clots in vitro.凝块相关（衍生）凝血酶在体外纤维蛋白凝块诱导的细胞增殖中的作用。
Br J Pharmacol. 2000 Mar;129(5):1021-7. doi: 10.1038/sj.bjp.0703137.
5
Lytic Susceptibility, Structure, and Mechanical Properties of Fibrin in Systemic Lupus Erythematosus.系统性红斑狼疮中纤维蛋白的溶解析出、结构和力学性能。
Front Immunol. 2019 Jul 16;10:1626. doi: 10.3389/fimmu.2019.01626. eCollection 2019.
6
A comparison of the mechanical, kinetic, and biochemical properties of fibrin clots formed with two different fibrin sealants.两种不同纤维蛋白密封剂形成的纤维蛋白凝块的力学、动力学和生化特性比较。
Blood Coagul Fibrinolysis. 2011 Jan;22(1):19-23. doi: 10.1097/MBC.0b013e32833fcbfb.
7
Use of Simvastatin, Fibrin Clots, and Their Combination to Improve Human Ovarian Tissue Grafting for Fertility Restoration After Anti-Cancer Therapy.使用辛伐他汀、纤维蛋白凝块及其组合改善人类卵巢组织移植，以恢复抗癌治疗后的生育能力。
Front Oncol. 2021 Jan 22;10:598026. doi: 10.3389/fonc.2020.598026. eCollection 2020.
8
Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.将片段X掺入纤维蛋白凝块会使其更容易被纤溶酶溶解。
Biochemistry. 2006 Apr 4;45(13):4257-65. doi: 10.1021/bi0525730.
9
Differential increased survival of staphylococci and limited ultrastructural changes in the core of infected fibrin clots after daptomycin administration.达托霉素给药后葡萄球菌的差异生存增加以及感染纤维蛋白凝块核心处有限的超微结构变化。
Antimicrob Agents Chemother. 1996 Jan;40(1):203-11. doi: 10.1128/AAC.40.1.203.
10
Blood clot fracture properties are dependent on red blood cell and fibrin content.血栓的断裂特性取决于红细胞和纤维蛋白的含量。
Acta Biomater. 2021 Jun;127:213-228. doi: 10.1016/j.actbio.2021.03.052. Epub 2021 Mar 31.

本文引用的文献

1
Altered fibrin clot properties in advanced lung cancer: impact of chemotherapy.晚期肺癌中纤维蛋白凝块特性的改变：化疗的影响。
J Thorac Dis. 2018 Dec;10(12):6863-6872. doi: 10.21037/jtd.2018.11.19.
2
Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment.癌症相关血栓形成：机制、危险因素及治疗概述
Cancers (Basel). 2018 Oct 11;10(10):380. doi: 10.3390/cancers10100380.
3
Venous Thromboembolism and Cancer.静脉血栓栓塞症与癌症。
Curr Cardiol Rep. 2018 Aug 20;20(10):89. doi: 10.1007/s11886-018-1034-3.
4
Cancer-associated pathways and biomarkers of venous thrombosis.癌症相关的静脉血栓形成途径和生物标志物。
Blood. 2017 Sep 28;130(13):1499-1506. doi: 10.1182/blood-2017-03-743211. Epub 2017 Aug 14.
5
Enhanced procoagulant activity of platelets after chemotherapy in non-small cell lung cancer.化疗后非小细胞肺癌血小板促凝活性增强。
Cancer Biol Ther. 2017 Aug 3;18(8):627-634. doi: 10.1080/15384047.2017.1345387. Epub 2017 Jul 18.
6
Tissue Factor As a Predictor of Recurrent Venous Thromboembolism in Malignancy: Biomarker Analyses of the CATCH Trial.组织因子作为恶性肿瘤复发性静脉血栓栓塞的预测因子：CATCH 试验的生物标志物分析。
J Clin Oncol. 2017 Apr 1;35(10):1078-1085. doi: 10.1200/JCO.2016.67.4564. Epub 2016 Dec 28.
7
Epidemiology of cancer-associated venous thrombosis.癌症相关静脉血栓形成的流行病学。
Blood. 2013 Sep 5;122(10):1712-23. doi: 10.1182/blood-2013-04-460121. Epub 2013 Aug 1.
8
Breast cancer chemotherapy induces the release of cell-free DNA, a novel procoagulant stimulus.乳腺癌化疗诱导无细胞 DNA 的释放，这是一种新型的促凝刺激物。
J Thromb Haemost. 2011 Nov;9(11):2313-21. doi: 10.1111/j.1538-7836.2011.04465.x.
9
Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases.纤维蛋白凝块的结构和功能：在动脉和静脉血栓栓塞性疾病的病理生理学中的作用。
Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):e88-99. doi: 10.1161/ATVBAHA.111.230631. Epub 2011 Aug 11.
10
Venous thromboembolism and prognosis in cancer.静脉血栓栓塞症与癌症预后。
Thromb Res. 2010 Jun;125(6):490-3. doi: 10.1016/j.thromres.2009.12.023. Epub 2010 Jan 25.